MedTrace Logo

Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery

NCT02975661 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 740

Last updated 2023-10-25

No results posted yet for this study

Summary

Registration of patients after gastrointestinal cancer radical surgery, including the information of treatments, recurrence \& metastasis, adverse events,etc.

Conditions

Sponsors & Collaborators

  • Second Hospital of Jilin University

    collaborator OTHER

  • Huazhong University of Science and Technology

    collaborator OTHER

  • Qidong Gaitianli Medicines Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Tongjun Liu, PhD · Second Hospital of Jilin University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-04
Primary Completion
2023-10-20
Completion
2024-02-29

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975661 on ClinicalTrials.gov